表紙
市場調查報告書

全球自體免疫疾病 (AID) 診斷市場:各疾病,各檢驗類型,各地區,企業分析

Autoimmune Disease Diagnostic Market, By Disease, Tests Type, Regions, Global Forecast

出版商 Renub Research 商品編碼 616030
出版日期 內容資訊 英文 137 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球自體免疫疾病 (AID) 診斷市場:各疾病,各檢驗類型,各地區,企業分析 Autoimmune Disease Diagnostic Market, By Disease, Tests Type, Regions, Global Forecast
出版日期: 2019年09月01日內容資訊: 英文 137 Pages
簡介

全球自體免疫疾病 (AID) 診斷市場,預計超過180億美元。

本報告提供全球自體免疫疾病 (AID) 診斷市場相關調查分析,市場規模與預測,市場佔有率,市場分析,企業的簡介等系統性資訊。

第1章 摘要整理

第2章 全球自體免疫疾病 (AID) 診斷市場

第3章 市場佔有率

第4章 各疾病

  • 全身性
  • 侷限性

第5章 各檢驗類型

  • 自我抗體檢驗
  • 抗核抗體 (ANA) 檢驗
  • 全血球數檢驗
  • 紅血球沉澱速度檢驗
  • C反應性蛋白質 (CRP) 檢驗
  • 尿液檢查
  • 生物化學檢驗
  • 其他

第6章 各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第7章 Abbott Laboratories:企業分析

  • 概要
  • 事業策略
  • 財務考察

第8章 Siemens Healthineers:企業分析

  • 概要
  • 事業策略
  • 財務考察

第9章 Roche Diagnostics:企業分析

  • 概要
  • 事業策略
  • 財務考察

第10章 EUROIMMUN AG:企業分析

  • 概要
  • 事業策略
  • 財務考察

第11章 bioMerieux SA:企業分析

  • 概要
  • 事業策略
  • 財務考察

第12章 Quest Diagnostic:企業分析

  • 概要
  • 事業策略
  • 財務考察

第13章 Bio-Rad Laboratories:企業分析

  • 概要
  • 事業策略
  • 財務考察

第14章 促進市場成長的要素

  • 點1
  • 點2

第15章 市場面臨的相關課題

  • 點1
  • 點2

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Autoimmune disease refers to disease where immune system produces antibodies that kill or attack healthy cells or tissues. The immune system work is to provide protection against germs such as bacteria and virus. In autoimmune disease immune system wrongly attacks patients body. According to American Autoimmune Related Diseases Association, autoimmune disease affects fifty million Americans in which 25% are male and 75% are female. The Global Autoimmune Disease Diagnostic Market is expected to surpass US$ 18 Billion by the year end of 2025.

Although there are 80 Types of Autoimmune Diseases, but 14 most Common Autoimmune Diseases are as follows:

Rheumatoid Arthritis, Psoriasis/psoriatic arthritis, Multiple sclerosis, Type 1 diabetes, Inflammatory bowel disease, Systemic Lupus Erythematosus (SLE), Addison's disease, Sjogren's syndrome, Graves' disease, Hashimoto's thyroiditis, Myasthenia gravis, Autoimmune vasculitis, Celiac disease, Pernicious anemia.

Factors Driving the Autoimmune Disease Diagnostic Market

Rising technological advancement in diagnostic, increasing patient awareness towards early diagnostic of disease, increasing government healthcare expenditure, increasing per capita expenditure on health, favorable government policies, industry positive initiative towards autoimmune disease and rising research & development on autoimmune will further propel the market of autoimmune disease diagnostic market in the future course of time.

Renub Research report titled "Autoimmune Disease Diagnostic Market, By Disease (Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE), others), Localized], Tests Type (Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C-Reactive Protein Tests, Urinalysis, Comprehensive Metabolic Panel, Others) Regions (North America, Europe, Asia-Pacific & Rest of World), Companies (Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories) Global Forecast" provides a complete analysis of Global Autoimmune Disease Diagnostic Market.

Segment Insight by Disease

In this report, we have categorized the autoimmune disease diagnostic market on the basis of disease into two parts; Systemic autoimmune disease diagnostics and Localized autoimmune disease diagnostics. Systemic autoimmune disease diagnostics market are further fragmented into three parts; Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Rheumatoid Arthritis. In addition, we have also explained the technological development of autoimmune diagnostic.

Autoantibody Tests is one of the Largest Test of Autoimmune Disease Diagnostic Tests

In this report, we have categorized the autoimmune disease diagnostic market by test type into seven parts along with comprehensive assessment and factor that will boost the diagnostic test market. These tests are Autoantibody, Antinuclear Antibody, Complete Blood Count, Erythrocyte Sedimentation Rate, C - reactive protein Tests, Urinalysis and Comprehensive Metabolic Panel.

Regional Insight - North America is the Most Important Region for Autoimmune Disease Diagnostic Market

In this report, we have segmented the autoimmune disease diagnostic test market on the basis of four important regions; North America, Europe, Asia-Pacific and ROW. In addition, we have also done the multi-factor analysis for regional growth of autoimmune disease diagnostic market.

Companies Analysis

Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, EUROIMMUN AG, bioMerieux SA, Quest Diagnostic and Bio-Rad Laboratories are some of the top companies operating in the global autoimmune disease diagnostic; which has been studied thoroughly in the report.

All the 7 Companies Studied in the Report have been Studied from 3 Points

  • Company Overview
  • Business Strategy /Mergers & Acquisition
  • Financial Insight

This report provides a complete analysis of the Autoimmune Disease Diagnostic Market, Growth Drivers, Challenges, and their projections for the upcoming years.

Autoimmune Disease Diagnostic Segments Covered in the Report:

  • Systemic autoimmune disease diagnostics market
    • Rheumatoid Arthritis
    • Ankylosing Spondylitis
    • Systemic Lupus Erythematosus (SLE)
    • Others
  • Localized autoimmune disease diagnostics
    • Inflammatory Bowel Disease
    • Type 1 Diabetes
    • Thyroid
    • Other Localized Autoimmune Diseases

Regional Market Covered in the Report:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Key Companies Covered in the Report:

  • Abbott Laboratories
  • Siemens Healthineers
  • Roche Diagnostics
  • EUROIMMUN AG
  • bioMerieux SA
  • Quest Diagnostic
  • Bio-Rad Laboratories

Table of Contents

1. Executive Summary

2. Global Autoimmune Diseases Diagnostic Market

3. Market Share - Global Autoimmune Diseases Diagnostic

  • 3.1. By Disease - Global Autoimmune Diseases Diagnostic
  • 3.2. By Disease - Systemic Autoimmune Diseases Diagnostic
  • 3.3. By Region - Global Autoimmune Diseases Diagnostic

4. By Disease - Global Autoimmune Diseases Diagnostic Market

  • 4.1. Systemic Autoimmune Disease
    • 4.1.1. Rheumatoid Arthritis
    • 4.1.2. Ankylosing Spondylitis
    • 4.1.3. Systemic Lupus Erythematosus (SLE)
    • 4.1.4. Others
  • 4.2. Localized Autoimmune Disease Diagnostics
    • 4.2.1. Inflammatory Bowel Disease
    • 4.2.2. Type 1 Diabetes
    • 4.2.3. Thyroid
    • 4.2.4. Other Localized Autoimmune Diseases

5. By Test Type - Global Autoimmune Diseases Diagnostic Market

  • 5.1. Autoantibody Tests
  • 5.2. Antinuclear Antibody (ANA) Tests
  • 5.3. Complete Blood Count Tests
  • 5.4. Erythrocyte Sedimentation Rate Tests
  • 5.5. C-reactive protein (CRP) Tests
  • 5.6. Urinalysis Tests
  • 5.7. Comprehensive Metabolic Panel Tests
  • 5.8. Others Tests

6. By Region - Global Autoimmune Diseases Diagnostic Market

  • 6.1. North America
  • 6.2. Europe
  • 6.3. Asia Pacific
  • 6.4. Rest of the World (ROW)

7. Abbott Laboratories - Company Analysis

  • 7.1. Overview
  • 7.2. Business Strategy
    • 7.2.1. Point A
    • 7.2.2. Point B
    • 7.2.3. Point D
    • 7.2.4. Point E
  • 7.3. Financial Insight

8. Siemens Healthineers - Company Analysis

  • 8.1. Overview
  • 8.2. Business Strategy
    • 8.2.1. Point A
    • 8.2.2. Point B
    • 8.2.3. Point C
  • 8.3. Financial Insight

9. Roche Diagnostics - Company Analysis

  • 9.1. Overview
  • 9.2. Roche Holding AG Key Development
  • 9.3. Business Strategy
    • 9.3.1. Point A
    • 9.3.2. Point B
    • 9.3.3. Point C
  • 9.4. Financial Insight

10. EUROIMMUN AG - Company Analysis

  • 10.1. Overview
  • 10.2. Business Strategy
    • 10.2.1. Point A
    • 10.2.2. Point B
  • 10.3. Financial Insight

11. bioMerieux SA - Company Analysis

  • 11.1. Overview
  • 11.2. Business Strategy
    • 11.2.1. Point A
    • 11.2.2. Point B
    • 11.2.3. Point C
  • 11.3. Financial Insight

12. Quest Diagnostic - Company Analysis

  • 12.1. Overview
  • 12.2. Business Strategy
    • 12.2.1. Point A
    • 12.2.2. Point B
    • 12.2.3. Point C
    • 12.2.4. Point D
    • 12.2.5. Point E
  • 12.3. Financial Insight

13. Bio-Rad Laboratories - Company Analysis

  • 13.1. Overview
  • 13.2. Business Strategy
    • 13.2.1. Point A
    • 13.2.2. Point B
    • 13.2.3. Point C
  • 13.3. Financial Insight

14. Growth Drivers

  • 14.1. Rising Incidence of Autoimmune Diseases
  • 14.2. High Occurrence of Rheumatoid Arthritis

15. Challenges

  • 15.1. Industry Challenges by Product Differentiation
  • 15.2. High Costs of Equipment for Diagnosis of Autoimmune Diseases

List of Figures

  • Figure 2-1: Global Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
  • Figure 2-2: Forecast for Global Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
  • Figure 3-1: By Product - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 - 2018
  • Figure 3-2: By Product - Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2019 - 2025
  • Figure 3-3: By Diseases - Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2011 - 2018
  • Figure 3-4: By Diseases - Forecast for Global Systemic Autoimmune Diseases Diagnostic Market Share (%), 2019 - 2025
  • Figure 3-5: By Region - Global Autoimmune Diseases Diagnostic Market Share (%), 2011 - 2018
  • Figure 3-6: By Region - Forecast for Global Autoimmune Diseases Diagnostic Market Share (%), 2018 - 2024
  • Figure 4-1: Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2018
  • Figure 4-2: Forecast for Systemic Autoimmune Disease Diagnostics Market (Billion US$), 2019 - 2025
  • Figure 4-3: Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2011 - 2018
  • Figure 4-4: Forecast for Rheumatoid Arthritis Disease Diagnostics Market (Billion US$), 2019 - 2025
  • Figure 4-5: Ankylosing Spondylitis disease diagnostics market (Million US$), 2011 - 2018
  • Figure 4-6: Forecast for Ankylosing Spondylitis disease diagnostics market (Million US$), 2019 - 2025
  • Figure 4-7: Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2011 - 2018
  • Figure 4-8: Forecast for Systemic Lupus Erythematosus disease diagnostics market (Billion US$), 2019 - 2025
  • Figure 4-9: Others Systemic autoimmune disease diagnostics market (Billion US$), 2011 - 2018
  • Figure 4-10: Forecast for Other Systemic autoimmune disease diagnostics market (Billion US$), 2019 - 2025
  • Figure 4-11: Localized Autoimmune Disease Diagnostics Market (Billion US$), 2011 - 2019
  • Figure 4-12: Forecast for Localized Autoimmune Disease Diagnostics Market (Billion US$), 2019 - 2025
  • Figure 4-13: Global - Inflammatory Bowel Disease Diagnostic Market (Million US$), 2011 - 2018
  • Figure 4-14: Global - Forecast for Inflammatory Bowel Disease Diagnostic Market (Million US$), 2019 - 2025
  • Figure 4-15: Global - Type 1 Diabetes Diagnostic Market (Million US$), 2011 - 2018
  • Figure 4-16: Global - Forecast for Type 1 Diabetes Diagnostic Market (Million US$), 2019 - 2025
  • Figure 4-17: Global - Thyroid Diagnosed Market (Million US$), 2011 - 2018
  • Figure 4-18: Global - Forecast for Thyroid Diagnosed Market (Million US$), 2019 - 2025
  • Figure 4-19: Global - Other Localized Autoimmune Disease Diagnostic Market (Million US$), 2011 - 2018
  • Figure 4-20: Global - Forecast for Other Localized Autoimmune Disease Diagnostic Market (Million US$), 2019 - 2025
  • Figure 5-1: Autoantibody Tests Market (Million US$), 2011 - 2018
  • Figure 5-2: Forecast for Autoantibody Tests Market (Million US$), 2019 - 2025
  • Figure 5-3: Antinuclear Antibody Tests Market (Million US$), 2011 - 2018
  • Figure 5-4: Forecast for Antinuclear Antibody Tests Market (Million US$), 2019 - 2025
  • Figure 5-5: Complete Blood Count Market (Million US$), 2011 - 2018
  • Figure 5-6: Forecast for Complete Blood Count Market (Million US$), 2019 - 2025
  • Figure 5-7: Erythrocyte Sedimentation Rate Market (Million US$), 2011 - 2018
  • Figure 5-8: Forecast for Erythrocyte Sedimentation Rate Market (Million US$), 2019 - 2025
  • Figure 5-9: C-reactive protein Test Market (Million US$), 2011 - 2018
  • Figure 5-10: Forecast for C-reactive protein Test Market (Million US$), 2019 - 2025
  • Figure 5-11: Urinalysis Market (Million US$), 2011 - 2018
  • Figure 5-12: Forecast for Urinalysis Market (Million US$), 2019 - 2025
  • Figure 5-13: Comprehensive Metabolic Panel Market (Million US$), 2011 - 2018
  • Figure 5-14: Forecast for Comprehensive Metabolic Panel Market (Million US$), 2019 - 2025
  • Figure 5-15: Others Autoimmune Diseases Test Market (Million US$), 2011 - 2018
  • Figure 5-16: Forecast for Others Autoimmune Diseases Test Market (Million US$), 2019 - 2025
  • Figure 6-1: North America Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
  • Figure 6-2: Forecast for North America Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
  • Figure 6-3: Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
  • Figure 6-4: Forecast for Europe Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
  • Figure 6-5: Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
  • Figure 6-6: Forecast for Asia Pacific Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
  • Figure 6-7: Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2011 - 2018
  • Figure 6-8: Forecast for Rest of World Autoimmune Diseases Diagnostic Market (Billion US$), 2019 - 2025
  • Figure 7-1: Abbot Laboratories 'Diagnostics' Sales (Million US$), 2014 - 2018
  • Figure 7-2: Forecast for Abbot Laboratories 'Diagnostics' Sales (Million US$), 2019 - 2025
  • Figure 8-1: Siemens Healthineers 'Healthcare' Sales (Million USD) 2014 - 2018
  • Figure 8-2: Forecast for Siemens Healthineers 'Healthcare' Sales (Million USD) 2019 - 2025
  • Figure 9-1: Roche Diagnostics 'Diagnostic' Sales (Billion USD), 2014 - 2018
  • Figure 9-2: Forecast for Roche Diagnostics 'Diagnostic' Sales (Billion USD), 2019 - 2025
  • Figure 10-1: Euroimmun AG Net Sales (Million USD), 2014 - 2018
  • Figure 10-2: Forecast for Euroimmun AG Net Sales (Million US$), 2019 - 2025
  • Figure 11-1: biomerieux SA Net Sales (Million USD), 2014 - 2018
  • Figure 11-2: Forecast for biomerieux SA Net Sales (Million USD), 2019 - 2025
  • Figure 12-1: Quest Diagnostic Net Sales (Million US$), 2014 - 2018
  • Figure 12-2: Forecast for Quest Diagnostic Net Sales (Million US$), 2019 - 2025
  • Figure 13-1: Bio-Red Laboratories Net Sales (Million US$), 2014 - 2019
  • Figure 13-2: Forecast for Bio-Red Laboratories Net Sales (Million US$), 2019 - 2025
  • Figure 14-1: Prevalence of Diagnosed Autoimmune Conditions in Selected Countries as of 2017
  • Figure 14-2: Arthritis in U.S (Million) 2017 - 2024
  • Figure 14-3: Prevalence of rheumatoid arthritis, by age and sex, 2014-15

List of Tables

  • Table 4-1: Human Systemic Autoimmune Diseases
  • Table 4-2: Human Localized Autoimmune Diseases
  • Table 5-1: Normal Complete Blood Count Result
  • Table 8-1: Prevalence Data for Selected Autoimmune Diseases Listed - 2010
  • Table 8-2: US Prevalence Data for Selected Autoimmune Diseases Listed - 2012
Back to Top